
Regenerative medicine in Japan.Understand it first,then decide.
Direct links with Japanese hospitals and clinics, doctors and hospitals matched to you, record translation, a remote video consultation, an interpreter at every visit and follow-up at home. Consultation and coordination are free.
5 questions · about 2 minutes · an advisor replies within one working day
- 2014
- Regenerative Medicine Act
- 3 classes
- Regulated by risk
- 4,464
- Institutions in the MHLW register
From choosing a hospital to follow-up at home, one advisor coordinates it all
We work directly with hospitals and clinics in Japan. Tell an advisor about your situation and we arrange the matching, translation, video consultation and interpreting; treatment is provided by medical institutions in Japan.
- Direct links with Japanese hospitals and clinicsOur partners are hospitals and clinics in Japan that provide regenerative medicine under Japanese law; names and credentials are available on request.
- Doctors and hospitals matched to youWe look at your goals, records and travel plans, then shortlist suitable doctors and hospitals.
- Medical record translationYour records and test reports translated so the doctor in Japan can read them directly.
- Remote video consultationTalk to a Japanese doctor by video before you decide whether to travel.
- Interpreter at every visitAn interpreter stays with you for consultations, consent signing and treatment in Japan.
- Follow-up after you returnAfter you get home, your advisor keeps you connected with the doctor in Japan for check-ups and questions.
- Typical arrangements with our partner clinics: once your records are ready, the trip to Japan can usually be arranged within 2 weeks of your first enquiry; an autologous adipose-derived stem cell course usually runs about 6 to 12 months, with regular trips to Japan for each infusion. Your doctor sets the actual plan after the consultation.
- Prices differ by hospital. The cost is made up of cell collection and culture, the number of infusions, tests, and travel and stay in Japan; an advisor gives you a quote for the specific hospital.
Three steps from understanding to asking the right questions
Understand
Learn how Japan regulates regenerative medicine, what the three risk classes mean and which class the area you care about generally falls into.
How Japan regulates it →Pre-screen
Answer 5 questions and get a list of documents to prepare and questions to ask the clinic.
Start the pre-screening →Talk to an advisor
Send your result to an advisor. You hear back within one working day, and we match you with doctors and hospitals and arrange record translation and a video consultation.
How to reach an advisor →Seven topics, read by what you care about
Every topic follows the same method: what it is, how Japan regulates it, and what to confirm before you go.
- 01Stem cell basicsWhat stem cells are and how the types differ
- 02Regulation in JapanThe Act, three risk classes, provision plans
- 03Conditions and areasJoints, diabetes, Parkinson’s, ovarian insufficiency and more
- 04Immune cell and NK cell therapyHow immune cell therapy is classified in Japan
- 05Anti-agingStem cells, exosomes, PRP, NAD+
- 06iPS cells and researchApprovals of iPS cell-derived products
- 07Getting treated in JapanVisa, process, costs, interpreting
How Japan regulates regenerative medicine
Japan regulates regenerative medicine under a dedicated law. Five things to know before you go.
- 2014.11
The Act on the Safety of Regenerative Medicine takes effect
Japan regulates regenerative medicine under the Act on the Safety of Regenerative Medicine (再生医療等の安全性の確保等に関する法律, Act No. 85 of 2013), in force since November 2014.
- Before treatment
A provision plan first; skipping it is illegal
Before offering regenerative medicine, a medical institution must prepare a “provision plan for regenerative medicine”, have it reviewed by a certified committee for regenerative medicine, and submit it to the MHLW through the “e-再生医療” system. Offering treatment without completing these steps is illegal and is penalized.
- 3 classes
Three classes by risk
Class I is high risk, Class II medium risk and Class III low risk. Review is done by a “Specially Certified Committee for Regenerative Medicine”, or by a “Certified Committee for Regenerative Medicine” that reviews Class III only.
- 2025.05.31
Amendment brings in in vivo gene therapy
The amended Act (Act No. 51 of 2024) took effect, bringing in vivo gene therapy that does not use processed cells under the Act as well.
- 2026.09.02
An information and reporting window opens
The MHLW opened an information and reporting window for regenerative medicine that takes reports of illegal practice or safety concerns.
8 questions to ask before you go
Whichever clinic and treatment you are considering, ask these 8 questions before you pay or sign anything.
- Has a “provision plan for regenerative medicine” been prepared and submitted for this treatment?Offering it without completing the procedure is illegal in Japan.
- Is it Class I, Class II or Class III, and which committee reviewed it?The class determines which committee does the review.
- Will my own cells or donor cells be used? Where are they processed, and how long does it take?Where and how long the cells are processed shapes your travel plans.
- How many steps are there, how many trips to Japan, and how long is each stay?You need this to plan leave, a companion and flights.
- What is every item in the total cost? Are tests and cell processing charged separately?Most regenerative medicine is self-pay care, priced by the clinic and paid in full by the patient.
- What side effects are possible, and who handles them in Japan and after I return home?Agree on how problems after you return will be handled before you go.
- Will an English interpreter be present at the consultation and consent? Can I get the consent form in English in advance?Understanding what you sign matters more than keeping to schedule.
- How is follow-up handled after I return? Can I have copies of my records and test reports?Your doctor at home will need them.
Latest articles
Guides are on the way
Our editors are preparing the first guides topic by topic, each with its sources and the date it was checked. Meanwhile, start with these pages.
Answers to the five most common questions
Is stem cell treatment legal in Japan?
Japan regulates regenerative medicine under the Act on the Safety of Regenerative Medicine, in force since November 2014. Before offering it, a medical institution must prepare a provision plan, have it reviewed by a certified committee and submit it to the Ministry of Health, Labour and Welfare; offering treatment without doing so is illegal. So the question to ask is whether the clinic you are considering has submitted a plan for the specific treatment you want.
What do Class I, Class II and Class III regenerative medicine mean?
The Act sorts regenerative medicine by risk into Class I (high), Class II (medium) and Class III (low). Generally, iPS and ES cells are Class I; treatments using the patient’s own somatic stem cells (such as adipose-derived stem cells) are generally Class II; somatic cell processing without stem cells, such as immune cell therapy, is generally Class III. PRP depends on how it is used: injection into a joint or other “non-homologous use” is Class II, while dental and similar uses are mostly Class III. The class of a specific treatment is whatever the clinic’s submitted plan states.
Is regenerative medicine in Japan covered by insurance?
Most regenerative medicine in Japan is “free medical care” (jiyū shinryō): it is outside the public health insurance system, the clinic sets the price and the patient pays in full. Products that have received conditional approval fall under insurance separately and are not the same thing as a clinic’s self-pay treatments.
What visa do I need to get treatment in Japan?
Under the guidelines of the Ministry of Foreign Affairs and other ministries, a person traveling for medical care can apply for a medical stay visa or for an ordinary short-stay visa that fits the trip. Clients who travel with our coordination usually enter Japan for a short-term stay and handle their own visa; an advisor tells you what to prepare for your itinerary.
How can I tell whether a clinic has submitted a provision plan?
Send the clinic name and the treatment name to our advisor and we will check for you whether it has submitted a provision plan.
Source: Ministry of Health, Labour and Welfare (MHLW), "再生医療・細胞医療・遺伝子治療について" (Regenerative, cell and gene therapy); Ministry of Foreign Affairs, METI and Japan Tourism Agency guidelines on guarantors for the medical stay visa; Japan Tourism Agency / Ministry of Economy, Trade and Industry (METI) registration criteria for guarantor organizations; checked 2026-11. The information on this site is general information and is not medical advice; whether any therapy suits you can only be decided by a doctor after an in-person consultation.